PF-05082566

PF-05082566 Uses, Dosage, Side Effects, Food Interaction and all others data.

PF-05082566 is under investigation in clinical trial NCT03318900 (T Cell Immunotherapy for Advanced Ovarian Cancer).

Trade Name PF-05082566
Generic Utomilumab
Utomilumab Other Names PF-05082566, Utomilumab
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
PF-05082566
PF-05082566

Innovators Monograph

You find simplified version here PF-05082566

*** Taking medicines without doctor's advice can cause long-term problems.
Share